CATIE Blog | Page 34 | HIV and hepatitis C news and opinions

Conversations That Matter – Sex Workers and PrEP at CAHR 2017

May 16, 2017 • By Andrew Sorfleet

The possible unintended consequences of the introduction of PrEP to the sex industry is something that has been discussed in international sex work advocacy since at least 2012. So, when I saw that new PrEP prescription guidelines for Canada were being drafted, stating that “sex-trade workers” were a “significant risk of having transmissible HIV,” I was troubled that there had been no community consultation whatsoever. National guidelines required a national convening.

Shame Canada: Canadian Task Force ignores expert advice in new hepatitis C screening guidelines

April 28, 2017 • By Jennifer van Gennip

The Canadian Task Force on Preventative Health Care (CTFPHC) released its HCV Screening Guidelines today in the Canadian Medical Association Journal on Monday. To the dismay of experts across Canada including hepatitis C specialists, advocacy groups, and stakeholders, the new screening guidelines ignore expert advice regarding who should be tested for Hep C, setting a dangerous public health policy where dollars come first and the health of Canadians comes last.

Does price dictate HCV drug policy?

April 18, 2017 • By Amanda Fletcher

Early this year, British Columbia, Alberta, Saskatchewan, Quebec and Ontario announced the lowering of eligibility requirements for access to public coverage for life-changing hepatitis C drugs, including Epclusa, Zepatier, daclatasvir and asunaprevir. These drugs will be available to those with lower fibrosis scores for the first time (the greater the fibrosis score, the more severe the liver scarring, or cirrhosis, caused by disease.)[i]

Comment s’assurer que les actions de sécurité publique ne contreviennent pas à la mise en place de stratégies de réduction des méfaits ?

March 27, 2017 • By Anik Tremblay

La transmission du VIH et du VHC constitue encore aujourd’hui un problème de santé publique de première importance. Certains comportements, comme l’usage de drogues par injection et par inhalation, entraînent des risques importants de transmission. En effet, selon les données de surveillance [i], 15 % des personnes qui vont dans les centres d’accès au matériel d’injection et d’inhalation sont infectées au VIH et 63 % au VHC.

5 bonnes nouvelles à Ottawa pour le mieux-être des gars qui aiment les gars

March 20, 2017 • By Roberto Ortiz

À Ottawa, les gars gais, bisexuels, bispirituels, queer et d’autres gars qui aiment gars, que nous soyons cis ou trans (GBT2Q), avons de quoi être fiers. Ce sont des membres de nos communautés qui ont fondé MAX, le premier organisme avec un mandat de santé globale GBT2Q de l’Ontario (et le troisième au Canada). Cet hiver et ce printemps, voici cinq autres bonnes nouvelles pour le bien-être de nos communautés :

Women + PrEP: 5 Important Facts

February 28, 2017 • By Molly Bannerman

The emergence of PrEP has highlighted important gender inequalities in HIV transmission and HIV prevention. PrEP, or pre-exposure prophylaxis, is a drug that HIV-negative people (including women!) can take to help prevent HIV; however, most discussions about PrEP focus on men. Despite representing fewer new HIV infections than men, women also need innovative HIV prevention methods.